Alpha Cognition ACOG
NASDAQ ACOG
$9.75 +0.25 (+2.63%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alpha Cognition (ACOG) Gains from Investment Securities (2023 - 2025)

Alpha Cognition (ACOG) posted quarterly Gains from Investment Securities of -$3.7 million for Q3 2025, down 520.51% year-over-year from $873175.9 in Q3 2024, and down 170.99% quarter-over-quarter from $5.2 million in Q2 2025.

Alpha Cognition (ACOG) Gains from Investment Securities (2023 - 2025) Analysis & Trends

Alpha Cognition's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$3.7 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Alpha Cognition 219.48 Mn 178.04 Mn 5.70 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 -3.67 Mn
Sep 30, 2025 -3.67 Mn
Jun 30, 2025 5.17 Mn
Jun 30, 2025 5.17 Mn
Sep 30, 2024 -591,736.00
Sep 30, 2024 -591,736.00
Jun 30, 2024 -187,056.00
Jun 30, 2024 -187,056.00
Sep 30, 2023 515,771.00
Sep 30, 2023 515,771.00
Jun 30, 2023 71,856.00
Jun 30, 2023 71,856.00